Skip to main content
OpenTrials
Completed

NCT Number: NCT01061086

An Epidemiological Study of Acute Coronary Syndromes in The Greek Population. The TARGET Study

This is a multicenter, 2-phase observational study of acute coronary syndromes (ACS) in Greece, designed to provide real world data on the risk factors of patients presenting to a hospital emergency department with an index event, as well as to depict the current management practices and outcomes of these clinical conditions in Greece.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Coronary Syndromes Acute Coronary Syndrome Cardiovascular Diseases Heart Diseases Myocardial Ischemia Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Athens, Attica, Greece

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of an ACS (STEMI, NSTEMI, UA).
  • Informed Consent

Exclusion criteria

  • Involvement in the planning and conduct of the study (applies to both AstraZeneca staff and staff at the study sites).
  • Participation in other clinical study in period between the index event and 6- month follow-up assessment with the exception of registering in registries or surveys not influencing the management of the ACS.

Treatment and study plan

Primary outcomes

  1. To evaluate the proportion of patients who are on target for LDL-C according to the 2004-updated NCEP ATPIII guidelines as calculated within the first 24-hours of hospital admission for an ACS.

    Time frame: first visit - 1st day (cross-sectional part)

  2. To estimate the proportion of patients enrolled in the cross-sectional part of the study that experiences a Major Adverse Cardiovascular Event (MACE) within a 6-month follow-up period.

    Time frame: follow up visit - 6th month (prospective part)

Secondary outcomes

  1. To estimate the proportion of patients admitted to the hospital with STEMI, NSTEMI and unstable angina.

    Time frame: first visit - 1st day (cross-sectional part)

  2. To estimate the "pain-to-door-time" throughout different regions in Greece.

    Time frame: first visit - 1st day (cross-sectional part)

  3. To estimate the time to first MACE and to estimate CV, non-CV and all cause mortality within the 6-month period following the index ACS event.

    Time frame: follow up visit - 6th month (prospective part)

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Collaborators

  • Hellenic Cardiovascular Research Society

Registry information

Official study title

An Epidemiological Study of Acute Coronary Syndromes in The Greek Population

Acronym: TARGET

Important dates

Study start
2010
Primary completion
2010
Study completion
2011
First posted
Feb 2, 2010
Registry last updated
Dec 21, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.